Esperion Therapeutics
ESPR
#6609
Rank
HK$6.42 B
Marketcap
HK$24.93
Share price
0.00%
Change (1 day)
176.14%
Change (1 year)

Esperion Therapeutics (ESPR) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : HK$6.03 Billion

According to Esperion Therapeutics's latest financial reports the company's total liabilities are HK$6.03 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Esperion Therapeutics - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31HK$5.97 B5.05%
2024-12-31HK$5.68 B10.2%
2023-12-31HK$5.16 B15.53%
2022-12-31HK$4.46 B-0.98%
2021-12-31HK$4.51 B29.49%
2020-12-31HK$3.48 B129.99%
2019-12-31HK$1.51 B200.68%
2018-12-31HK$0.50 B94.55%
2017-12-31HK$0.25 B101.03%
2016-12-31HK$0.12 B99.92%
2015-12-31HK$64.43 M-14.56%
2014-12-31HK$75.4 M131.37%
2013-12-31HK$32.59 M-82.98%
2012-12-31HK$0.19 B199.3%
2011-12-31HK$63.97 M
2002-12-31HK$98.76 M6.95%
2001-12-31HK$92.33 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
HK$918.82 B 15,113.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$74.03 B 1,125.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
HK$11.95 B 97.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
HK$0.51 B-91.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
HK$5.29 B-12.31%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$18.64 B 208.76%๐Ÿ‡บ๐Ÿ‡ธ USA